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Osteopetrosis is a rare genetic disorder characterized bya failure of osteoclast-mediated bone resorption andby hematologic abnormalities. A patient with osteo-petrosis presenting with a distal esophagus cancer and
secondary hypersplenism was surgically treated.
Clinical Summary
The patient is a 57-year-old man with osteopetrosis since child-
hood, complicated by multiple orthopedic fractures (Figure 1),
osteomyelitis, splenomegaly, thrombocytopenia, and chronic ane-
mia requiring routine blood transfusions. Several months before
diagnosis, he was noted to have an increasing transfusion require-
ment. The hemoglobin fell to 2.6 g/dL, and upper endoscopy
demonstrated bleeding from an adenocarcinoma at the gastro-
esophageal junction (Figure 2).
An exploratory procedure was performed through a left thora-
coabdominal incision. The diaphragm was divided circumferen-
tially. A splenectomy was performed with a subsequent intraop-
erative platelet transfusion. The esophagus was divided at the level
of the inferior pulmonary vein and removed en bloc with the
proximal stomach and associated lymphoid tissue. The anastomo-
sis was created by using a combined hand-sewn and stapled
technique. Pathologic examination revealed a poorly differentiated
adenocarcinoma, measuring 3.3 cm and invading the submucosa,
with lymphovascular invasion and metastasis in 1 of 14 lymph
nodes. The enlarged spleen demonstrated extramedullary hemato-
poiesis.
The patient tolerated the procedure well. His postoperative
course was complicated by a pulmonary embolism, treated with a
vena cava filter. He was discharged on postoperative day 10 eating
a regular diet, with a dramatically reduced requirement for blood
and platelet transfusion. The total utilization of blood products was
13 units of packed red blood cells, 13 units of platelets, and 2 units
of fresh frozen plasma.
After discharge from the hospital, the patient’s quality of life
was substantially improved owing to resolution of symptoms, as
well as a durable elimination of his transfusion requirement. Ap-
proximately 18 months after his operation, weight loss and func-
tional decline ensued due to liver metastases; 22 months after his
operation, he died of progressive metastatic disease.
Comment
Although all patients with osteopetrosis have dense, fragile bones
and obliteration of the marrow space, other manifestations of the
disease vary. Osteopetrosis has traditionally been separated into 2
forms: infantile “malignant” and adult “benign.”1 Clinically, the
infantile form manifests with rickets-like bony changes, hepato-
splenomegaly, progressive pancytopenia, cranial neuropathies, and
susceptibility to infection.2 This disease is lethal in infancy or early
childhood, except in some children treated with human leukocyte
antigen–matched bone marrow transplantation.
The adult, benign form of osteopetrosis may be asymptomatic,
or pathologic fractures and osteomyelitis may occur. Severe he-
matologic disturbances and hepatosplenomegaly are usually
absent.3 The patient described here does not fit easily into the
infantile or adult form of osteopetrosis and probably had an atten-
uated form of the infantile disease or an intermediate type of
osteopetrosis.
Splenectomy has been used as a palliative procedure for pa-
tients with infantile osteopetrosis and hypersplenism since the
1960s.4 The primary concern with a splenectomy is the removal of
a major site of extramedullary hematopoiesis in patients with little
functioning bone marrow. To predict which patients will benefit
from a splenectomy, one may use hematologic and radionuclide
(bone marrow scintigraphy, red blood cell survival) studies to
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Figure 1. Preoperative chest x-ray film reveals the dense skele-
ton of osteopetrosis and a chronic left humeral fracture.
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determine the relative contributions of decreased red cell produc-
tion and increased destruction to a patient’s anemia and thrombo-
cytopenia.2,4,5
Although this patient’s comorbidities substantially increased
his risk for perioperative complications, we felt that surgery was
the best treatment option because we believed that the patient’s
severe bleeding and hypersplenism could be most effectively ad-
dressed with surgery. We also believe that surgery provides the
best chance for cure in locally advanced esophageal cancer, while
avoiding potential bone marrow toxicity from nonoperative cancer
treatments. In this case, we decided on a left thoracoabdominal
approach because we believed that the patient’s bleeding diathesis
placed him at risk for excessive bleeding with blunt esophageal
dissection. In addition, the thoracoabdominal approach provides
superior exposure to the enlarged spleen compared with an anterior
abdominal incision.
Additional considerations when operating on a patient with
osteopetrosis include prevention of iatrogenic fractures and dental
injuries, to which these patients are extremely susceptible, and
perioperative correction of anemia and thrombocytopenia. Collab-
oration with a hematologist is essential. Adjuvant therapy was not
prescribed because it was thought that the risk of hematologic
suppression in this patient was too great to justify the potential
benefit.
In summary, this is a report of esophagectomy and splenectomy
performed for esophageal adenocarcinoma and secondary hyper-
splenism in a patient with osteopetrosis. With proper preparation
and precautions, this high-risk patient underwent a major operation
with favorable early outcome. Suggestions for perioperative man-
agement of the patient with osteopetrosis are made, and the pal-
liative potential of splenectomy in osteopetrosis is highlighted.
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Figure 2. Abdominal computed tomographic scan showing
esophageal lesion and splenomegaly. S, Spleen; T, tumor.
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